| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.006 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.36 | 0.01 |